WUHAN HAMILTON BIOTECHNOLOGY

China (People China (People's Republic)
Sector: Health Care Providers
Ticker: null
Factsheet Factsheet

Market multiple valuation of WUHAN HAMILTON BIOTECHNOLOGY ( [#TICKER#] | CHN)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of WUHAN HAMILTON BIOTECHNOLOGY is significantly lower than the median of its peer group: around 20.00. The company valuation of WUHAN HAMILTON BIOTECHNOLOGY according to these metrics is way below the market valuation of its peer group.
The P/Earnings NTM ratio of WUHAN HAMILTON BIOTECHNOLOGY is significantly lower than the average of its sector (Health Care Providers): 20.60. The company valuation of WUHAN HAMILTON BIOTECHNOLOGY according to these metrics is way below the market valuation of its sector.
The P/Earnings NTM ratio of WUHAN HAMILTON BIOTECHNOLOGY is significantly lower than its historical 5-year average: N/A. The (current) company valuation of WUHAN HAMILTON BIOTECHNOLOGY is therefore way below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2021P/E NTM
WUHAN HAMILTON BIOTECHNOLOGYFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Health Care Providers16.1022.0320.60
N/AN/AN/AN/A
China (People's Republic)32.5121.3319.59
More...
Betanull
Levered betaUnlevered beta
1-YearN/AN/A
2-YearN/AN/A
3-YearN/AN/A
More...
Stock Perf excl. Dividends (in N/A)
N/AN/AN/A
Year-to-DateN/AN/AN/A
1-WeekN/AN/AN/A
1-MonthN/AN/AN/A
1-YearN/AN/AN/A
3-YearN/AN/AN/A
5-YearN/AN/AN/A
More...
International Peers - WUHAN HAMILTON BIOTECHNOLOGY
Company NameCtryMarket
Cap.
last (mUSD)
WUHAN HAMILTON BIOTECHN...CHNN/A
International Peers Median0.46
RWS Holdings plcGBR3 474
Amorepacific Corp.KOR15 218
Sonic Healthcare Limite...AUS12 652
Fagron SABEL1 628
Abivax SAFRA376
GPRV Analysis
GPRV® analysis is not available due to one of the
following reasons:
  • - Company is not covered by analysts (no estimates)
  • - Company is an insurance company
More...
Net Sales Chart
More...
Quotes Chart

1-Year Rebased Stock Chart

  • WUHAN HAMILTON BIOTECHNOLOGY
More...

Did you know ?

On the Infront Analytics platform, there are two ways to identify the listed peers which most closely resemble a private firm:
- with Peer Tracker if you already know a listed peer.
Peer Tracker is a patented technology tool for building peer groups using industry classifications. The degree of similarity between two companies is calculated comparing their sector footprints and measured using comparability scores.
- with Market Screener if you have no listed peer in mind.
Market Screener is a dedicated interface for screening companies using multiple criteria, identifying peers, searching for comparable companies in a specific business sector.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).